Product Images Sumatriptan
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 10 images provide visual information about the product associated with Sumatriptan NDC 71921-170 by Florida Pharmaceutical Products, Llc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
sumatriptan chemical structure - sumatriptan nasalspray spl graphic 01
Figure 1. estimated probability of initial headache response within 120 minutes - sumatriptan nasalspray spl graphic 02
This appears to be a graph showing the results of a study or experiment involving various doses of a drug (possibly a painkiller) versus a placebo, over a period of time up to 30 or 40 minutes after initial dosage. The drug is referred to in two doses, 4.5mg and 20mg, and is identified with the letter "g" in both instances. The placebo is labeled as "+ placebo." The graph shows the effectiveness of each dosage level over time, with the drug outperforming the placebo. The lower portion of the graph includes labels for different time intervals (0-15, 15-30, etc.) and a scale from 0 to 100%. The label "E" appears to be a typo or artifact of the process.*
figure 2. probability of patients needing second dose or additional medication - sumatriptan nasalspray spl graphic 03
figure A - sumatriptan nasalspray spl graphic 04
figure B - sumatriptan nasalspray spl graphic 05
figure C - sumatriptan nasalspray spl graphic 06
figure D - sumatriptan nasalspray spl graphic 07
Figure E - sumatriptan nasalspray spl graphic 08
Figure F - sumatriptan nasalspray spl graphic 09
Imitrex Nasal 20 mg 6 count carton - sumatriptan nasalspray spl graphic 10
This is a product description of Sumatriptan Nasal Spray, USP. Each unit contains 20g of sumatriptan with a dose of 0.1 L for intranasal use only. It comes with 6 nasal spray units. The usual dosage is indicated in the prescribing information, and it should be stored between 2°C and 30°C. The product is manufactured for Florida Pharmaceutical Products, LLC, and made in Canada. The inactive ingredients include monobasic potassium phosphate, anhydrous dibasic sodium phosphate USP, succinic acid NF, sodium chloride USP, and water for injection USP.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.